Expert Commentary
View AllPublications
Chronic opioid therapy and preventive services in rural primary care: an Oregon rural practice-based research network study.
A different kind of co-morbidity: Understanding posttraumatic stress disorder and chronic pain
The impact of enrollment in a specialized interdisciplinary neuropathic pain clinic
Association between urine drug test results and treatment outcome in high-risk chronic pain patients on opioids
The role of core strengthening for chronic low back pain.
Buckley DI, Calvert JF, Lapidus JA, et al.
Ann Fam Med. 2010;8(3):237-44.
PURPOSE:...
Ann Fam Med. 2010;8(3):237-44.
PURPOSE:...
A different kind of co-morbidity: Understanding posttraumatic stress disorder and chronic pain
Beck JG, Clapp JD.
Psychol Trauma. 2011 Jun;3(2):101-108.
Many traumatic events leave...
Psychol Trauma. 2011 Jun;3(2):101-108.
Many traumatic events leave...
The impact of enrollment in a specialized interdisciplinary neuropathic pain clinic
Garven A, Brady S, Wood S, Hatfield M, Bestard J, Korngut L, Toth C.
Pain Res Manag. 2011...
Pain Res Manag. 2011...
Association between urine drug test results and treatment outcome in high-risk chronic pain patients on opioids
Barth KS, Becker WC, Wiedemer NL, Mavandadi S, Oslin DW, Meghani SH, Gallagher RM.
J Addict...
J Addict...
The role of core strengthening for chronic low back pain.
Akuthota V, Standaert CJ, Chimes GP.
PM R. 2011 Jul;3(7):664-70.
PM R. 2011 Jul;3(7):664-70.






Diagnosis-Specific Management of Somatoform Disorders: Moving Beyond “Vague Complaints of Pain”
Anne Dohrenwend, PhD
University of Florida College of Dentistry
North Florida/South Georgia Veterans Health System
Gainesville, Florida
Characterized by unexplained somatic symptoms, often including pain amplification, somatoform disorders can be frustrating for clinicians to diagnosis and treat. In the United States, these patients use disproportionately high levels of medical resources and incur higher medical care–related costs. Deficiencies in management may stem from DSM-IV grouping in the somatoform category despite the at best weak etiologic homogeneity among the various disorders. This consequently leads to inappropriate generalizations when treating a disorder from this heterogeneous class. Appropriate diagnosis and optimized patient management requires an understanding of DSM-IV criteria for each of the seven individual disorders within this category. Patient-centered treatment of somatoform patients is based on assessment of such factors as affect, insight, and potential personality disorders. When somatic amplification is identified, clinicians should consider psychological testing and individualized multimodal therapy with a focus on functional outcomes.
References